Contact PI/Project LeaderHORNIK, CHRISTOPH Other PIs
Awardee OrganizationDUKE UNIVERSITY
Description
Abstract Text
In the United States, >79 million people have been infected with SARS-CoV-2 and >900,000 died, but cases
and deaths disproportionately affect underserved populations. Novel treatments early in disease may transform
the pandemic’s course, but strategies that address disparities in timely testing and drug access are essential to
maximize impact. Community driven interventions provided access to testing in underserved populations
earlier in the pandemic, but need to be tailored to promote test and treat protocols and rapid access to
treatment in response to current threats. This proposal will evaluate a systematic and scalable community-
engaged test and treat protocol that provides rapid access to self-testing, “next steps” guidance, and local
resources to facilitate treatment in underserved populations. We will evaluate a community engagement toolkit,
You & Me Healthy Toolkit, developed based on our expertise and experience, to implement community-based
test distribution and test and treat responses to the next phase of the COVID-19 pandemic in underserved
populations. Our central hypothesis is that that the You & Me Healthy Toolkit will enable rapid design and
implementation of a community driven, scientifically robust, and impactful COVID-19 test and
treatment intervention. We will leverage successful partnerships and infrastructure established through two
large national RADx-UP funded SARS-CoV2 testing and education interventions (SAY YES! COVID TEST,
You & Me COVID-Free); an actively enrolling registry of participants interested in community-engaged
research (You & Me Healthy Registry); partnerships with community engagement experts (Community
Campus Partnerships for Health); and a history of collaboration with 150+ local community partners in Merced
County, CA and Pitt County, NC with high proportion minority (Hispanic/Latino/Latinx and Black), high-poverty
and low health insurance coverage. We will apply this toolkit to develop a rapid-deployment test and treat
protocol implemented through our partners in two communities, launched in direct response to SARS-CoV2
infection surges or at community-identified high-risk events over a 15 month period. We will test this hypothesis
through the following specific aims: 1) Evaluate the YMH toolkit ability to rapidly create effective academic-
community research partnerships for promoting COVID-19 test access; 2) Document results of at-home tests
using a community-engaged scalable reporting approach; 3) Evaluate ability of a test and treat protocol and
local resourcing to facilitate timely access to testing, guidance, resource linkage, and therapeutics. This work
will demonstrate the value of a generalizable toolkit to promote rapid and effective academic-community
partnerships to enable timely testing and access to effective therapeutics in underserved populations in
response to COVID-19 surges or transmission threats.
Public Health Relevance Statement
PROJECT NARRATIVE
COVID-19 cases and deaths disproportionately affect underserved populations, but strategies that address
disparities in timely testing and drug access may transform the pandemic’s course. We will evaluate a
community engagement toolkit, You & Me Healthy Toolkit, to develop a rapid-deployment test and treat
protocol implemented through our partners in two communities, launched in direct response to SARS-CoV2
infection surges or at community-identified high-risk events over a 15-month period. This work will demonstrate
the value of a generalizable toolkit to promote rapid and effective academic-community partnerships to enable
timely testing and access to effective therapeutics in underserved populations in response to COVID-19 surges
or transmission threats.
National Institute on Minority Health and Health Disparities
CFDA Code
310
DUNS Number
044387793
UEI
TP7EK8DZV6N5
Project Start Date
01-November-2022
Project End Date
31-October-2025
Budget Start Date
01-November-2023
Budget End Date
31-October-2025
Project Funding Information for 2023
Total Funding
$1,096,719
Direct Costs
$688,542
Indirect Costs
$408,177
Year
Funding IC
FY Total Cost by IC
2023
NIH Office of the Director
$1,096,719
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 3U01MD018294-01S1
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 3U01MD018294-01S1
Patents
No Patents information available for 3U01MD018294-01S1
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 3U01MD018294-01S1
Clinical Studies
No Clinical Studies information available for 3U01MD018294-01S1
News and More
Related News Releases
No news release information available for 3U01MD018294-01S1
History
No Historical information available for 3U01MD018294-01S1
Similar Projects
No Similar Projects information available for 3U01MD018294-01S1